Delivery Order SPE2DB24D1034-SPE2DB25FWFB8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $1,010.54 under a firm fixed price contract. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.84 to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,944.80 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with a completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.27 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, non-set-aside contract was awarded competitively and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare systems for cardiovascular...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with a ceiling value of $8,619.00 and an ultimate completion date of August 8, 2025. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) valued at $2,191.03 under a firm fixed price contract. The award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and the product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside procurement executed through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with a firm fixed price ceiling value of $9,931.33 and an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.62 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken,...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFB8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,434.11 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count packages). This contract award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a cardiovascular medication commonly used in military and veteran healthcare systems to treat hypertension and heart failure, making it a critical component of the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a prime vendor for the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company was selected through competitive procurement and continues to support critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/18/25 |